Vertex Pharmaceuticals Incorporated
DNA-PK inhibitors
Last updated:
Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Status:
Grant
Type:
Utility
Filling date:
13 Aug 2019
Issue date:
18 May 2021